HOME >> BIOLOGY >> NEWS
Managing maternal depression during pregnancy presents significant challenge to clinicians

PITTSBURGH, May 18 Women who take antidepressants during the final trimester of pregnancy through delivery increase the risk of "neonatal behavioral syndrome," a constellation of symptoms and behaviors largely related to drug withdrawal or side effects, University of Pittsburgh researchers conclude in a review of medical literature. Such findings reveal an additional challenge for clinical management of depression during pregnancy, Eydie Moses-Kolko, M.D., assistant professor of psychiatry at the University of Pittsburgh School of Medicine, and her colleagues write in the May 18 issue of the Journal of the American Medical Association.

"The FDA and drug manufacturers recently agreed to label revisions for antidepressants known as selective serotonin reuptake inhibitors. Now the label for these drugs includes information about potential adverse effects to newborns if the drug is taken late in pregnancy," said Dr. Moses-Kolko, who also is on staff with the Women's Behavioral HealthCARE program of the Western Psychiatric Institute and Clinic of the University of Pittsburgh Medical Center. "Late exposure was associated with increased risk for a range of complications including jitteriness, stiffened muscle tone, irritability, respiratory distress and feeding problems."

While most cases of neonatal behavioral syndrome are mild and generally resolve in about two weeks, a number are severe enough to require neonatal intensive-care unit (NICU) hospitalization.

"Newborns exposed to antidepressants late in pregnancy had more than twice the risk of admission to a special-care nursery as those exposed only early in pregnancy," Dr. Moses-Kolko said, adding that late-exposed newborns also had twice the risk of respiratory complications some critical. "Respiratory distress ranged from congestion and rapid breathing to extreme danger requiring oxygen therapy and even mechanical ventilation," she said. "A severe syndrome with dehydration, mechanical ventila
'"/>


17-May-2005


Page: 1 2 3

Related biology news :

1. Endogenous cannabinoids linked to fetal brain damage imposed by maternal cannabis use
2. A few more minutes of maternal attachment may reduce anemia in children
3. Childrens Hospital Oaklands new maternal diet study
4. Childrens Hospital and Research Center-Oakland presents a new maternal diet study
5. Call for global action over continued huge burden of maternal deaths in poor countries
6. Preconception care crucial to improving maternal and infant health
7. Zebra finch males prefer females with exaggerated maternal traits
8. Infant bone growth and maternal vitamin D levels during pregnancy influence future fracture risk
9. Sex chromosome genes influence aggression andmaternal behavior, say UVa researchers
10. ASU researchers find link between social behavior, maternal traits in bees
11. Ingestion of afterbirth appears to promote maternal behavior in mammals

Post Your Comments:
(Date:3/26/2015)... The Granite Club, ... club, today announced it has implemented a state-of-the-art access ... for members and staff, while restricting access to authorized ... selected FST,s IMID Access system because it has the ... and staff, in addition to unparalleled security," said ...
(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
(Date:3/23/2015)... --  HOYOS Labs , a leading global authentication infrastructure ... Company will demonstrate multiple biometrics-based technologies under its identity ... on March 23 through 25, 2015, in ... IEEE Biometric Open Protocol Standard; free biometrics-based consumer app, ... system. BOPS was invented by HOYOS Labs and contributed ...
Breaking Biology News(10 mins):Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
(Date:4/23/2015)... Six startups from Russia traveled ... as part of the U.S.-Russia Innovation Corridor (USRIC) ... biotechnology startups to participate in the program since ... the University of Maryland (UMD) signed a Memorandum ... universities in the biomedical industry in 2013. , ...
(Date:4/23/2015)... SAN FRANCISCO, Calif. , April 23, 2015  Veracyte, ... has entered into a definitive agreement to sell approximately ... placement. Under the agreement, the investors will purchase an ... purchase price of $8.15 per share, the closing stock ... led by new and existing investors, including Broadfin Capital, ...
(Date:4/23/2015)... 2015  Propanc Health Group Corporation (OTCBB: PPCH) ... the development of cancer treatments for patients with ... includes PRP, a patented formulation consisting of two ... as the enzyme amylase designed to synergistically enhance ... of anti-cancer agents working in combination with pro-enzymes, ...
(Date:4/22/2015)... -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ) today reported ... For the first quarter ended March 31, 2015, ... or $0.08 per share, compared to a net loss ... same period in 2014. As of March 31, 2015, ... interest receivable of $226.1 million. Revenues for ...
Breaking Biology Technology:U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 2U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 3U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts 4Veracyte, Inc. Announces $40 Million Private Placement 2Veracyte, Inc. Announces $40 Million Private Placement 3Veracyte, Inc. Announces $40 Million Private Placement 4Early Stage BioTech offers Plenty of Risk; Propanc Health Group Analyst Brief Issued by BrokerBank Securities, Inc. 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 4Sangamo BioSciences Reports First Quarter 2015 Financial Results 5Sangamo BioSciences Reports First Quarter 2015 Financial Results 6Sangamo BioSciences Reports First Quarter 2015 Financial Results 7Sangamo BioSciences Reports First Quarter 2015 Financial Results 8
Cached News: